Silodosin is a selective antagonist of post-synaptic alpha-1 adrenoreceptors, which are located in the human prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra. Blockade of these alpha-1 adrenoreceptors can cause smooth muscle in these tissues to relax, resulting in an improvement in urine flow and a reduction in BPH symptoms.
Siloflo 4 Capsule: Each capsule contains Silodosin INN 4 mg.
Siloflo 8 Capsule: Each capsule contains Silodosin INN 8 mg.
Silodosin is indicated for the treatment of the signs and symptoms of Benign Prostatic Hyperplasia (BPH).
8 mg capsules taken orally once daily with a meal. 4 mg capsules taken orally once daily with a meal for those with moderate renal impairment [Creatinine Clearance (CCr) 30-50 mL/min].
Patients with severe renal & hepatic impairment, concomitant administration with strong Cytochrome P450 3A4 (CYP3A4) inhibitors (e.g., ketoconazole, clarithromycin, itraconazole, ritonavir) and patients with a history of hypersensitivity to Silodosin.
The most common adverse reactions are retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis and nasal congestion.
Pregnancy: Silodosin is not indicated for use in women.
Pediatric patients: Silodosin is not indicated for use in pediatric patients.
Renal impairment: Silodosin should be reduced to 4 mg per day in patients with moderate renal impairment. Silodosin is contraindicated in patients with severe renal impairment.
Hepatic impairment: No dosing adjustment is required in patients with mild or moderate hepatic impairment. Silodosin is contraindicated in patients with severe hepatic impairment.
Siloflo 4 Capsule: Each box contains 20 capsules in alu-alu blister pack.
Siloflo 8 Capsule: Each box contains 20 capsules in alu-alu blister pack.
Aristopharma Ltd. is one of the top 10 pharmaceutical companies in Bangladesh. The company started its journey in 1986 with the honest promise to provide quality medicines at affordable prices to the countrymen.
© 2023. Aristopharma Ltd. All rights reserved.